073. Tamoxifen - Associated Hirsutism: An Usual Side Effect in A 52-Year-Old Women with Malignant Neoplasm of Left Breast
Background: Hirsutism is a condition characterized by growth of excessive male-pattern (i.e., face, chest, abdomen, lower back, upper arms, and thighs) hair in women. The prevalence of hirsutism has been reported to be between 5% and 15% in women and can be caused by various factors, including the...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universitas Udayana
2024-11-01
|
| Series: | JBN (Jurnal Bedah Nasional) |
| Online Access: | https://ojs.unud.ac.id/index.php/jbn/article/view/120059 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846168342350528512 |
|---|---|
| author | Asri Asri Zainal Abidin |
| author_facet | Asri Asri Zainal Abidin |
| author_sort | Asri Asri |
| collection | DOAJ |
| description | Background: Hirsutism is a condition characterized by growth of excessive male-pattern (i.e., face, chest, abdomen, lower back, upper arms, and thighs) hair in women. The prevalence of hirsutism has been reported to be between 5% and 15% in women and can be caused by various factors, including the use of medications such as Tamoxifen. The modified Ferriman-Gallwey (mFG) score is the preferred and most widely used method for scoring excess terminal hair in the assessment of hirsutism. This case report aims to explore the relationship between Tamoxifen use and the development of hirsutism, as well as to discuss the potential mechanisms involved. Case: A 52-year-old female patient was diagnosed with a left breast tumor and underwent neoadjuvant chemotherapy followed by treatment with Tamoxifen 10 mg daily for six months. After treatment, the patient reported abnormal hair growth on her face, chest, arms, and legs. Conclusion: The use of Tamoxifen may contribute to the development of hirsutism in some patients. It is important to monitor these side effects and consider appropriate management strategies for patients experiencing hirsutism related to treatment. |
| format | Article |
| id | doaj-art-836f9d152af6485dad832f762b58e15d |
| institution | Kabale University |
| issn | 2548-5962 2548-981X |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Universitas Udayana |
| record_format | Article |
| series | JBN (Jurnal Bedah Nasional) |
| spelling | doaj-art-836f9d152af6485dad832f762b58e15d2024-11-14T02:59:58ZengUniversitas UdayanaJBN (Jurnal Bedah Nasional)2548-59622548-981X2024-11-0182S73S7310.24843/JBN.2024.v08.is02.p073120059073. Tamoxifen - Associated Hirsutism: An Usual Side Effect in A 52-Year-Old Women with Malignant Neoplasm of Left BreastAsri Asri0Zainal Abidin1Surgery Department, Mulawarman University, Abdoel Wahab Sjahranie Regional General Hospital, Samarinda, East KalimantanSurgery Department, Mulawarman University, Abdoel Wahab Sjahranie Regional General Hospital, Samarinda, East KalimantanBackground: Hirsutism is a condition characterized by growth of excessive male-pattern (i.e., face, chest, abdomen, lower back, upper arms, and thighs) hair in women. The prevalence of hirsutism has been reported to be between 5% and 15% in women and can be caused by various factors, including the use of medications such as Tamoxifen. The modified Ferriman-Gallwey (mFG) score is the preferred and most widely used method for scoring excess terminal hair in the assessment of hirsutism. This case report aims to explore the relationship between Tamoxifen use and the development of hirsutism, as well as to discuss the potential mechanisms involved. Case: A 52-year-old female patient was diagnosed with a left breast tumor and underwent neoadjuvant chemotherapy followed by treatment with Tamoxifen 10 mg daily for six months. After treatment, the patient reported abnormal hair growth on her face, chest, arms, and legs. Conclusion: The use of Tamoxifen may contribute to the development of hirsutism in some patients. It is important to monitor these side effects and consider appropriate management strategies for patients experiencing hirsutism related to treatment.https://ojs.unud.ac.id/index.php/jbn/article/view/120059 |
| spellingShingle | Asri Asri Zainal Abidin 073. Tamoxifen - Associated Hirsutism: An Usual Side Effect in A 52-Year-Old Women with Malignant Neoplasm of Left Breast JBN (Jurnal Bedah Nasional) |
| title | 073. Tamoxifen - Associated Hirsutism: An Usual Side Effect in A 52-Year-Old Women with Malignant Neoplasm of Left Breast |
| title_full | 073. Tamoxifen - Associated Hirsutism: An Usual Side Effect in A 52-Year-Old Women with Malignant Neoplasm of Left Breast |
| title_fullStr | 073. Tamoxifen - Associated Hirsutism: An Usual Side Effect in A 52-Year-Old Women with Malignant Neoplasm of Left Breast |
| title_full_unstemmed | 073. Tamoxifen - Associated Hirsutism: An Usual Side Effect in A 52-Year-Old Women with Malignant Neoplasm of Left Breast |
| title_short | 073. Tamoxifen - Associated Hirsutism: An Usual Side Effect in A 52-Year-Old Women with Malignant Neoplasm of Left Breast |
| title_sort | 073 tamoxifen associated hirsutism an usual side effect in a 52 year old women with malignant neoplasm of left breast |
| url | https://ojs.unud.ac.id/index.php/jbn/article/view/120059 |
| work_keys_str_mv | AT asriasri 073tamoxifenassociatedhirsutismanusualsideeffectina52yearoldwomenwithmalignantneoplasmofleftbreast AT zainalabidin 073tamoxifenassociatedhirsutismanusualsideeffectina52yearoldwomenwithmalignantneoplasmofleftbreast |